In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
501 News Items found
scan of mouse blood vessel
In the Lab
Surprising Discovery Connects Rare Vascular Disease to Cancer Gene

Researchers found that a common cancer gene called PIK3CA also causes the condition venous malformation. Their discovery has already pointed the way to targeted therapies for this rare and painful condition that affects one in 10,000 people.
Tumor mutation model
Finding
Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers

Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.
Zsofia Stadler
Finding
Knowledge of Inherited Gene Mutations Increasingly Can Guide Cancer Treatment

An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.
A researcher working in an MSK lab
MSK Research Highlights, September 4, 2025

New MSK research shows the Make-an-IMPACT program improves global access to genomic testing in pediatric cancer patients; helped develop an experimental antibody that shows promise against metastatic cancer; sheds light on the origins of ERG-driven prostate cancer; and finds Dupilumab is a successful agent to treat skin toxicities related to antibody-drug conjugates.
Woman holding long-haired black cat.
Lung Cancer Caught Early: Marylou’s Story

A lifelong smoker overcomes discomfort over what a lung cancer imaging test might reveal. She hopes her experience helps reduce the stigma for others who smoke.
Harold Varmus former CEO of MSK
Harold Varmus: A Decade of Leadership at MSK

Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.
A doctor examines a mole.
Finding
Don't Scratch That Mole? Scientists Are Learning More about Inflammation and Cancer

It's not only what's inside your cells that determines your cancer risk. It's what surrounds them too.
Mike Philbin
Finding
How Telemedicine Reshaped Genetic Counseling during the COVID-19 Pandemic

A recent study from MSK investigators found that most patients who received genetic counseling by telemedicine during the early months of the pandemic reported being highly satisfied with the care they received.
Seen are Scott Stuart, MSK Chair, Board of Trustees, and Selwyn M. Vickers, MD, FACS, President and CEO of MSK
A Message From MSK Leaders Selwyn M. Vickers and Scott Stuart

The President and CEO and Chair of the Board at Memorial Sloan Kettering Cancer Center introduce the year's highlights in their introductory letter to the 2023 Annual Report.
Students pose with Memorial Sloan Kettering President Harold Varmus after the symposium.
Major Trends in Modern Cancer Research

The third annual research symposium introduces high school students and teachers to several topics in cancer research.